Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -903 | 61,022 | -209,248 | -152,904 | -111,654 |
| Depreciation Amortization | 889 | 437 | 1,449 | 1,012 | 559 |
| Accounts receivable | -11,866 | -6,118 | -14,765 | -8,894 | -7,070 |
| Accounts payable and accrued liabilities | 15,898 | -3,450 | 8,678 | 3,174 | 1,518 |
| Other Working Capital | -26,802 | -21,803 | 13,675 | 9,720 | 3,141 |
| Other Operating Activity | 69,407 | 23,740 | 64,724 | 49,461 | 34,400 |
| Operating Cash Flow | $46,623 | $53,828 | $-135,487 | $-98,431 | $-79,106 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -150 | -73 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | 42,500 | 42,500 | 42,500 |
| Investing Cash Flow | $-150 | $-73 | $42,500 | $42,500 | $42,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 105,509 | 96,438 | 65,966 | 56,897 | 56,917 |
| Other Financing Activity | -44,926 | -5,832 | -15,506 | -10,908 | -6,616 |
| Financing Cash Flow | $60,583 | $90,606 | $50,460 | $45,989 | $50,301 |
| Beginning Cash Position | 82,248 | 82,248 | 124,775 | 124,775 | 124,775 |
| End Cash Position | 189,304 | 226,609 | 82,248 | 114,833 | 138,470 |
| Net Cash Flow | $107,056 | $144,361 | $-42,527 | $-9,942 | $13,695 |
| Free Cash Flow | |||||
| Operating Cash Flow | 46,623 | 53,828 | -135,487 | -98,431 | -79,106 |
| Capital Expenditure | -150 | -73 | N/A | 0 | N/A |
| Free Cash Flow | 46,473 | 53,755 | -135,487 | -98,431 | -79,106 |